Analyst drops price target for heart device makers
From AP News | 2010-02-08 16:52:13
<div id="subtitle">Analyst drops price target for heart device makers, sees lower sales of defibrillators</div><div><p>A Goldman Sachs analyst has lowered price targets for two medical device makers and added a third sell-rated company to its "Americas Conviction" list after forecasting slow growth for implantable cardioverter defibrillators.</p><p>Analyst David H. Roman lowered 12-month price targets on Boston Scientific Corp. to $9 from $10 and on Medtronic to $43 from $47. St. Jude Medical Inc. also was added to the Goldman Sachs "Americas Conviction" list, as its rating was maintained at "Sell." The list represents recommendations focused on either the size of a potential return or the likelihood of the realization of the return, according to Goldman Sachs.</p><p>Vendor consolidation and increased price competition from manufacturers will contribute to slow growth this year for the defibrillators, which are used to treat abnormal heart rhythms, said a note from the analyst. The note said they think consensus sales and earnings-per-share projections for St. Jude are too high.</p><p>"As numbers come down, we expect the stock's (price-to-earnings) multiple to come under pressure," the note said.</p><p>Goldman Sachs surveyed 50 electrophysiologists and talked with doctors who suggested the market for the devices will slow this year.</p><p>"We think hospitals' efforts to consolidate vendors is a key driver of the increased pricing pressure in ICDs," the note said. "Specifically, around 23 (percent) of the respondents in our survey indicated that their hospitals had stepped up their efforts to consolidate vendors."</p><p>The analyst also noted that the companies, after multiple recalls, are operating at full capacity for the first time in nearly four years.</p><p>St. Jude shares fell 4 cents to $37.59 in afternoon trading, while Medtronic shares rose 47 cents to $42.14 and Boston Scientific added 1 cent to $8.22. Meanwhile, the Standard &amp; Poor's 500 index gained less than 1 percent.</p><img src="http://admatch-syndication.mochila.com/images/ad.gif?aid=68698943&bid=informcom" /></div><div id="copyright"><div>
Copyright 2010 <a href="http://www.ap.org">AP News</a></div></div>
Related Video by 5min
Related Articles
- Municipal officials push for power to design benefits plans Boston Globe | 2010-03-13 22:39:39
- Legislators are wrong to point fingers Boston Globe | 2010-03-13 22:39:39
- Blue Cross executives' compensation soars as controversy rages over health insurance premium increases Crain's: Chicago | 2010-03-13 15:54:30
- Contraceptive-coverage bill passes Colorado Senate Dayton Business Journal | 2010-03-13 17:36:16
- GOP's Ryan Dissects ObamaCare, Lays Out 'Roadmap' To Health Yahoo! Finance | 2010-03-13 21:38:19
- Paul Krugman: Health reform myths Pittsburgh Post-Gazette | 2010-03-13 01:08:21
Related Blogs
- Myth and Fact: Organizing for America Misinformation on Health Care Bill The ChamberPost | 2010-03-13 14:28:41
- The job locker Power Line | 2010-03-13 09:17:49
- Still diagnosing the problem The Economist: Democracy in America | 2010-03-13 17:39:45
- Simulating a Toyota “smoking gun” Overlawyered | 2010-03-13 14:22:33
- Crazy contd. - healthcare premiums PharmaGossip | 2010-03-13 10:30:37
Related Video
- Students hear Obama message CNN Video | 2010-03-08 13:15:32
- Health insurance monopoly CNN Video | 2010-03-12 09:03:00